NCT06292273View on ClinicalTrials.gov

Bupivacaine With Dexmedetomidine Versus Bupivacaine Alone for Transversus Abdominis Plane Block in Caesarean Section

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 20, 2024

Conditions
Post Operative Pain
Interventions
PROCEDURE

Transversus Abdominis Plane Block with bupivacain Plus dexamethasone

Bupivacain 0.1%, 35 ml with dexmedetomidine 0.5 µG/kg on each side

PROCEDURE

Transversus Abdominis Plane Block with bupivacain

plain bupivacaine 0.25%, 25 ml bilaterally

Trial Locations (1)

32511

Faculty of Medicine Menoufia University, Cairo

All Listed Sponsors
lead

Menoufia University

OTHER

NCT06292273 - Bupivacaine With Dexmedetomidine Versus Bupivacaine Alone for Transversus Abdominis Plane Block in Caesarean Section | Biotech Hunter | Biotech Hunter